查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1474903

總體基因體學市場規模、佔有率、趨勢分析報告：依產品、技術、工作流程、應用、區域、細分市場預測，2024-2030

Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10個工作天內

價格

總體基因體學市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球總體基因體學市場規模預計將達到 48.2 億美元。

預計2024年至2030年市場將以13.52%的複合年成長率擴張。基因組學和蛋白​​質組學研究的增加、個人化藥物的採用增加以及對生物製藥的需求不斷增加正在推動對測序儀的需求，從而推動行業成長。例如，2022 年 8 月，Illumina, Inc. 宣布計劃透過開發解決方案中心來擴大其在巴西的基因組學業務。新設施的創建是臨床基因組學需求不斷成長和加速公司在拉丁美洲的足跡的結果。

據估計，各公司活性化的研發投資將對總體基因體學在許多應用中的使用產生重大影響。例如，2021年4月，安捷倫科技公司收購了Resolution Bioscience, Inc.，一家基於NGS的精準腫瘤學解決方案開發商。 Resolution Bioscience 的非侵入性液態切片平台與安捷倫基於組織的伴同性診斷技術的結合預計將擴大安捷倫在精準腫瘤學 NGS 技術領域的市場地位。

總體基因體學在環境應用中廣泛採用的另一個因素是微生物直接參與生物地球化學循環。微生物對石油碳氫化合物等碳源的分解促使研究人員研究生質燃料生產的總體基因體學過程。此外，未培養的微生物中存在許多未被發現的生物分子，加速了總體基因體學在農業、食品安全、化學、工業和其他相關應用中的採用。

自 COVID-19 爆發以來，生命科學和生物技術行業的主要相關人員一直在尋求追蹤、檢測和治療 COVID-19 的解決方案。總體基因體學分析在病毒檢測和追蹤中發揮重要作用。已經部署了各種序列監測平台和解決方案來有效診斷感染。例如，2021 年 5 月，牛津大學和Oracle宣佈建立策略合作夥伴關係，開發強大的雲端基礎的基因組定序和分析平台，以降低冠狀病毒感染的風險。

此外，政府為鼓勵使用NGS平台進行學術研究而提供的資金將進一步增加總體基因體學工具的使用。例如，2021 年 2 月，加拿大政府投資 5,300 萬美元實施多層方法來診斷 COVID-19。加拿大政府計劃利用基因組序列測定和分析技術來實現預期結果。

總體基因體學成的資料品質也是增加分析成本的因素。資料品質很大程度取決於序列測定過程中的平均運行次數。高品質的分析是有代價的。然而，由於 RNA-Seq 等新技術的準確性和快速結果以及價格的下降，其採用正在迅速增加。據觀察，定序成本每年增加5-10倍，運算能力每兩年增加一倍。

總體基因體學市場報告亮點

  • 2023年，套件和試劑業務收益佔有率最大，超過61.48%。套件和試劑專為特定應用而設計，例如土壤、水和生物樣本分析。
  • 2023年，霰彈槍定序領域的收益佔有率最大，為34.08%。霰彈槍定序透過將 DNA 隨機分成小片段並對每個片段進行定序來對整個基因組進行定序。
  • 定序序細分市場在2023年以53.39%的收益佔有率佔據市場主導地位。這一成長歸功於定序技術進步所實現的成本效益和準確性。
  • 2023年，環保領域以25.02%的收益佔有率主導市場。元基因組研究在農業和環境保護中的作用正在迅速擴大，利用序列分析和基因篩檢來了解特定環境中的微生物，代表了了解微生物生態系統的新方法。
  • 2023年總體基因體學市場由北美主導，收益佔有率為40.26%。該地區的主導地位取決於主要企業的存在、研發資金的增加以及測序技術的進步。
  • 預計亞太地區在預測期內將以最快的複合年成長率成長。這是由印度和中國在多種應用中採用總體基因體學的重大進展所推動的。

目錄

第1章總體基因體學市場：調查方法與範圍

第2章總體基因體學市場：執行摘要

  • 市場概述
  • 段簡介
  • 競爭格局概覽

第3章總體基因體學市場：變數、趨勢、範圍

  • 市場體系展望
  • 市場趨勢及展望
  • 市場動態
  • 市場限制因素分析
  • 營商環境分析
  • COVID-19 影響分析

第4章總體基因體學市場：產品業務分析

  • 細分儀表板
  • 全球總體基因體學市場：產品變異分析
  • 2018-2030年全球總體基因體學市場規模與趨勢分析（依產品）

第5章總體基因體學市場：技術的商業分析

  • 細分儀表板
  • 全球總體基因體學市場：技術波動分析
  • 2018-2030 年全球總體基因體學市場規模與趨勢分析（按技術）

第6章總體基因體學市場：工作流程的商業分析

  • 細分儀表板
  • 全球總體基因體學市場：工作流程變化分析
  • 2018-2030 年全球總體基因體學市場規模與趨勢分析（依工作流程）

第7章總體基因體學市場：應用的商業分析

  • 細分儀表板
  • 全球總體基因體學市場：應用變異分析
  • 2018-2030 年全球總體基因體學市場規模與趨勢分析（按應用）

第8章區域業務分析

  • 區域儀表板
  • 2018-2030 年市場規模與預測/趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 參與企業
  • 策略規劃
  • 2023 年企業市場分析
  • 參與企業概況
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • PerkinElmer, Inc
    • Thermo Fisher Scientific, Inc
    • Novogene Co., Ltd.
    • Promega Corporation
    • QIAGEN
    • Takara Bio, Inc.
    • Oxford Nanopore Technologies plc.
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-2-68038-452-9

Metagenomics Market Growth & Trends:

The global metagenomics market size is expected to reach USD 4.82 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.52% from 2024 to 2030. The increasing research in genomics and proteomics, the rising adoption of personalized medicines, and escalating requirement for biologic products are driving the demand for sequencing, fueling the growth of the industry. For instance, in August 2022, Illumina, Inc. announced its plans to expand genomics operations in Brazil by developing a solution center. The establishment of the new facility is the result of rising demand for clinical genomics and accelerating the company's footprint in Latin America.

A boost in R&D investments by the players is estimated to have a considerable impact on the usage of metagenomics in numerous applications. For instance, in April 2021, Agilent Technologies, Inc. acquired Resolution Bioscience, Inc., an NGS-based precision oncology solution developing company. The combination of Resolution Bioscience's noninvasive liquid biopsy platform with Agilent's tissue-based companion diagnostics is anticipated to expand Agilent's market position in NGS technologies for precision oncology.

Another factor contributing to the high adoption of metagenomics for environmental use is the direct involvement of microorganisms in the biogeochemical cycle. The degradation of carbon sources such as petroleum hydrocarbons by microbes has encouraged researchers to study metagenomics processes for the production of biofuels. In addition, the presence of a large number of undiscovered biomolecules in non-cultured microorganisms accelerated the adoption of metagenomics in agriculture, food safety, chemical, industrial, and other related applications.

Since the outbreak of COVID-19, key stakeholders in the life sciences and biotechnology industry are seeking solutions for COVID-19 tracking, detection, and treatment. Metagenomics analysis plays a crucial role in the detection and tracing of the virus. Various sequencing surveillance platforms and solutions are being deployed for effective diagnosis of infection. For instance, in May 2021, Oxford University and Oracle announced a strategic partnership to develop robust cloud-based genomic sequencing and analysis platform to mitigate the risk of coronavirus infection.

Moreover, funds provided by the government for promoting research in academic institutes, which use NGS platforms, further increase the usage of metagenomics tools. For instance, in February 2021, the Canadian government invested USD 53 million to implement a multilayered approach for the diagnosis of COVID-19. The Canadian government will utilize genome sequencing and analysis technologies to achieve desired outcomes.

The quality of data generated through metagenomics is another factor that increases the cost of analysis. The quality of data is highly dependent on the average number of times the bases are run during the sequencing process. The high-quality analysis is expensive. However, the adoption of emerging novel techniques, such as RNA-Seq, is rapidly increasing owing to accuracy and rapid results along with a decline in prices. It is observed that the cost of sequencing falls 5 to 10 times every year and the value of computing power doubles every two years.

Metagenomics Market Report Highlights:

  • The kits & reagents segment held the largest revenue share of over 61.48% in 2023. Kits & reagents are designed for specific applications, such as soil, water, and biological sample analysis.
  • The shotgun sequencing segment accounted for the largest revenue share of 34.08% in 2023. Shotgun sequencing sequences entire genomes by randomly breaking up DNA into small fragments and then sequencing each fragment.
  • The sequencing segment dominated the market with revenue share of 53.39% in 2023. The increase can be attributed to the cost-effectiveness and accuracy achieved through technological advancements in sequencing.
  • In 2023, the environmental segment dominated the market with a revenue share of 25.02%. The role of metagenomics research is swiftly expanding in agriculture and environmental protection, employing sequencing analysis or gene screening to comprehend microorganisms within a specific environment, marking a novel approach to understanding microbial ecosystems.
  • North America dominated the metagenomics market in 2023 with a revenue share of 40.26%. The region's dominance is determined through the presence of key companies, augmented R&D funding, and advancements in sequencing technology.
  • Asia Pacific is expected to grow at the fastest CAGR during the forecast period. This is driven by substantial advancements in metagenomics adoption across diverse applications in India and China.

Table of Contents

Chapter 1. Metagenomics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Information analysis
    • 1.2.2. Market formulation & data visualization
    • 1.2.3. Data validation & publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Metagenomics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Metagenomics Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Declining expenses of sequencing
    • 3.3.2. Developments in biotechnology & bioinformatics techniques
    • 3.3.3. Rising interest in microbial screening for different investigations
    • 3.3.4. Emergence of new fields in genomics that complement metagenomics
  • 3.4. Market Restraint Analysis
    • 3.4.1. Limited accessibility to computation and different analytic tools
    • 3.4.2. High overall cost of metagenomics
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.5.2. Porter's Five Forces Analysis
  • 3.6. COVID - 19 Impact Analysis

Chapter 4. Metagenomics Market: Product Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Metagenomics Market Product Movement Analysis
  • 4.3. Global Metagenomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
    • 4.3.1. Kits and Reagents
      • 4.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.2. Sequencing & Data Analytics Services
      • 4.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.3. Software
      • 4.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 5. Metagenomics Market: Technology Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Metagenomics Market Technology Movement Analysis
  • 5.3. Global Metagenomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
    • 5.3.1. Shotgun Sequencing
      • 5.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.2. 16S Sequencing
      • 5.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.3. Whole Genome Sequencing
      • 5.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 6. Metagenomics Market: Workflow Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Metagenomics Market Workflow Movement Analysis
  • 6.3. Global Metagenomics Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
    • 6.3.1. Pre-sequencing
      • 6.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.3.2. Sequencing
      • 6.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.3.3. Data Analysis
      • 6.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 7. Metagenomics Market: Application Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Metagenomics Market Application Movement Analysis
  • 7.3. Global Metagenomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
    • 7.3.1. Environmental
      • 7.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.2. Clinical Diagnostics
      • 7.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.3. Drug Discovery
      • 7.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.4. Biotechnology
      • 7.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.5. Food & nutrition
      • 7.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 7.3.6. Others
      • 7.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.4. Spain
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.5. France
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.6. Italy
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. JAPAN
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Mexico Metagenomics Market, 2018 - 2030 (USD Million)
    • 8.6.4. Argentina
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Metagenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Participant's Overview
    • 9.4.1. Bio-Rad Laboratories, Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Illumina, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. PerkinElmer, Inc
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Thermo Fisher Scientific, Inc
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Novogene Co., Ltd.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Promega Corporation
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. QIAGEN
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Takara Bio, Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Oxford Nanopore Technologies plc.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. F. Hoffmann-La Roche Ltd.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Global Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 6 Global Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Sexual Health Supplements Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 9 North America Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 11 North America Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 12 North America Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 16 U.S. Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 20 Canada Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 22 Europe Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Europe Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 24 Europe Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 25 Europe Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 UK Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 UK Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 UK Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 29 UK Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Germany Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 32 Germany Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 33 Germany Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 34 France Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 France Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 36 France Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 37 France Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Italy Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 Italy Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 40 Italy Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 41 Italy Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Spain Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Spain Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 44 Spain Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 45 Spain Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 46 Sweden Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Sweden Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 48 Sweden Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 49 Sweden Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Norway Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Norway Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 52 Norway Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 53 Norway Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 Denmark Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 55 Denmark Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 Denmark Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 57 Denmark Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Japan Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 64 Japan Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 65 Japan Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 66 Japan Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 China Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 China Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 69 China Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 70 China Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 India Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 India Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 73 India Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 74 India Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 75 Australia Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 Australia Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 77 Australia Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 78 Australia Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 South Korea Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 81 South Korea Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 82 South Korea Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 83 Thailand Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Thailand Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 Thailand Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 86 Thailand Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 Latin America Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 88 Latin America Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 Latin America Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 90 Latin America Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 91 Latin America Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Brazil Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 Brazil Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 94 Brazil Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 95 Brazil Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Mexico Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Mexico Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 98 Mexico Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 99 Mexico Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 100 Argentina Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 102 Argentina Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 103 Argentina Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 104 MEA Metagenomics Market, Region, 2018 - 2030 (USD Million)
  • Table 105 MEA Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 106 MEA Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 107 MEA Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 108 MEA Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 109 South Africa Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 111 South Africa Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 112 South Africa Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 117 UAE Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 118 UAE Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 119 UAE Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 120 UAE Metagenomics Market, By Application, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Metagenomics Market, By Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Metagenomics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Metagenomics Market, By Workflow, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Metagenomics Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Metagenomics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Sexual health supplements market driver analysis
  • Fig. 14 Metagenomics market restraint analysis
  • Fig. 15 Metagenomics market: Porter's analysis
  • Fig. 16 Metagenomics market: PESTEL analysis
  • Fig. 17 Metagenomics market: Technology outlook and key takeaways
  • Fig. 18 Metagenomics market: Technology market share analysis, 2023 - 2030
  • Fig. 19 Global metagenomics by shotgun sequencing market, 2018 - 2030 (USD Million)
  • Fig. 20 Global metagenomics by 16S sequencing market, 2018 - 2030 (USD Million)
  • Fig. 21 Global metagenomics by whole genome sequencing market, 2018 - 2030 (USD Million)
  • Fig. 22 Global metagenomics by others market, 2018 - 2030 (USD Million)
  • Fig. 23 Metagenomics market: Product outlook and key takeaways
  • Fig. 24 Metagenomics market: Product market share analysis, 2023 - 2030
  • Fig. 25 Global metagenomics by kits & reagents market, 2018 - 2030 (USD Million)
  • Fig. 26 Global metagenomics by sequencing & data analytics services market, 2018 - 2030 (USD Million)
  • Fig. 27 Global metagenomics by software market, 2018 - 2030 (USD Million)
  • Fig. 28 Metagenomics market: Application outlook and key takeaways
  • Fig. 29 Metagenomics market: Application market share analysis, 2023 - 2030
  • Fig. 30 Global metagenomics by environmental market, 2018 - 2030 (USD Million)
  • Fig. 31 Global metagenomics by clinical diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 32 Global metagenomics by drug discovery market, 2018 - 2030 (USD Million)
  • Fig. 33 Global metagenomics by biotechnology market, 2018 - 2030 (USD Million)
  • Fig. 34 Global metagenomics by food & nutrition market, 2018 - 2030 (USD Million)
  • Fig. 35 Global metagenomics by others market, 2018 - 2030 (USD Million)
  • Fig. 36 Metagenomics market: Workflow outlook and key takeaways
  • Fig. 37 Metagenomics market: Workflow market share analysis, 2023 - 2030
  • Fig. 38 Global metagenomics by pre-sequencing market, 2018 - 2030 (USD Million)
  • Fig. 39 Global metagenomics by sequencing market, 2018 - 2030 (USD Million)
  • Fig. 40 Global metagenomics by data analysis market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional marketplace: Key takeaways
  • Fig. 42 North America metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. key country dynamics
  • Fig. 44 U.S. metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Canada key country dynamics
  • Fig. 46 Canada metagenomics market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Germany key country dynamics
  • Fig. 51 Germany metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 France key country dynamics
  • Fig. 53 France metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Italy key country dynamics
  • Fig. 55 Italy metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Spain key country dynamics
  • Fig. 57 Spain metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark key country dynamics
  • Fig. 59 Denmark metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden key country dynamics
  • Fig. 61 Sweden metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Norway key country dynamics
  • Fig. 63 Norway metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Asia-Pacific metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Japan key country dynamics
  • Fig. 66 Japan metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 China key country dynamics
  • Fig. 68 China metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 India key country dynamics
  • Fig. 70 India metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Australia key country dynamics
  • Fig. 72 Australia metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Thailand key country dynamics
  • Fig. 74 Thailand metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 South Korea key country dynamics
  • Fig. 76 South Korea metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Mexico key country dynamics
  • Fig. 81 Mexico metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Argentina key country dynamics
  • Fig. 83 Argentina metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 MEA metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 South Africa key country dynamics
  • Fig. 86 South Africa metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Saudi Arabia key country dynamics
  • Fig. 88 Saudi Arabia metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 UAE key country dynamics
  • Fig. 90 UAE metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Kuwait key country dynamics
  • Fig. 92 Kuwait metagenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Key company categorization
  • Fig. 94 Company market positioning
  • Fig. 95 Market participant categorization
  • Fig. 96 Strategy framework